作者:Donald C. Schlegel、Bernard L. Zenitz、Constance A. Fellows、Stanley C. Laskowski、D. Craig Behn、Donald K. Phillips、Irving Botton、Phyllis T. Speight
DOI:10.1021/jm00378a027
日期:1984.12
Replacement of the carboxyl group of 2-(3-benzoylphenyl)propionic acid (Ketoprofen) with various bulky amines has produced a series of highly active antiinflammatory agents that have reduced intestinal ulcerogenicity and have better therapeutic ratios in the 21-day adjuvant arthritis assay in rats than currently marketed nonsteroidal antiinflammatory drugs. Activity is maintained on reduction of these 2-(3
用各种笨重的胺取代2-(3-苯甲酰基苯基)丙酸(酮洛芬)的羧基已产生了一系列高活性抗炎药,这些药物在21天的佐剂性关节炎试验中具有降低的肠溃疡性和更好的治疗率。大鼠比目前市售的非甾体类抗炎药。将这些2-(3-苯甲酰基苯基)丙基大分子胺还原为相应的醇或亚甲基类似物,将酮官能团转化为伯胺或肟,以及引入4-卤代取代基(Cl或F)在芳环末端。去除α-CH3基团大大降低了该系列的抗炎活性。